Holland Capital realizes successful exit of Humeca to i4hi

Holland Capital realizes successful exit of Humeca to i4hi

Holland Capital realizes successful exit of Humeca to i4hi

Holland Capital realizes successful exit of Humeca to i4hi

Borne / Amsterdam, 5 July 2022 – Investment company Holland Capital realizes a successful exit of Humeca to fellow investor i4hi.

Humeca is a leading supplier of innovative products in the field of advanced skin grafting techniques and is the world market leader in the treatment of severe burns. The company’s internally developed revolutionary MEEK technology is superior to other transplant methods. In addition, Humeca offers various adjacent innovative products in the field of burn surgery. The company has built up a broad base of distributors serving customers in more than 70 countries worldwide with Humeca’s products.

Investment company Holland Capital offers active support

Holland Capital has been involved with Humeca as a shareholder since 2014. She has actively supported management in the strategic and commercial development of the company, including the opening of the US sales office. Hubert Verbeek, managing partner Holland Capital, about the exit: “We are extremely proud of what we have achieved together with the Humeca team over the past 8 years. We wish the team, together with i4hi, a lot of success in their next stage of growth.”

Arnoud van Velzen, managing director Humeca, “Supporting surgical burn teams and distributors worldwide in the application of our techniques is our passion. With great pride we look back on the collaboration with Holland Capital. With the participation of i4hi, we are excited to enter the next stage of growth.”

AMP Group acquires Omega Logistics business operations

AMP Group acquires Omega Logistics business operations

AMP Group acquires Omega Logistics business operations

AMP Group acquires Omega Logistics business operations

Houten, 23 May 2022 – Our portfolio company AMP is taking its second step in the buy-and-build strategy with the acquisition of the business activities of Omega Logistics, a medical logistics provider. Through this acquisition, which was made possible in part by Holland Capital, AMP strengthens its position within the medical logistics market.

Omega Logistics is a specialized logistics service provider that is primarily active in the pharmaceutical and healthcare sectors. The organization has its own temperature controlled distribution network that services hospitals, pharmacies, health care institutions and patients. Recently, the activities of Omega have been incorporated in Jan de Rijk Benelux, whose activities are now taken over by AMP.

Medical logistics market
By joining forces, AMP strengthens its position within the strongly growing strategic medical logistics market in both B2C and B2B. Marco van der Klij, Managing Director of AMP Group: “By merging the distribution network of Omega with ours, we can further expand the scale of our medical logistics network. This will allow us to play an even bigger role in this growing market.”

Fred Westdijk, CEO Jan de Rijk Logistics / Omega Logistics: “A clear market focus is crucial to serve customers successfully. The continued growth of Jan de Rijk Logistics in other business units has made the management decide to divest the activities of Omega Logistics in order to create more room for growth in other activities such as international transport, Benelux distribution, freight forwarding, contract logistics and intermodal transport. We are convinced that we found a good home for our customers and staff in AMP.”

Holland Capital has been involved as a shareholder in AMP since 2020. It actively supports the management in the strategic development of the company. Hubert Verbeek, managing partner Holland Capital: “The acquisition of Omega Logistics is, after joining forces with Delta Logistics at the end of last year, a great step in our buy-and-build strategy. With this, AMP further strengthens its leading position in medical logistics.”

About Omega Logistics
Omega Logistics was founded in 2011 and since 2015 has been part of Jan de Rijk Logistics, a provider of European transport and distribution services in the field of international transport, warehousing and distribution. 

About AMP Group
AMP is fully dedicated to B2C and B2B medical logistics and safe delivery of valuable and fraud-sensitive products where stringent security requirements, such as identification, must be met. For example, refrigerated medicines and valuable products such as telephones, confidential documents and passports, for which identification of the recipient is required, can be transported safely and efficiently from A to B via its nationwide network. In addition to the proprietary software to optimize customer experience and route planning, the company uses the latest technology in the field of ID authentication, facial recognition and biometric signature to accurately identify the recipient. With a team of over 300 employees and delivery staff, AMP works with organisations such as ABN AMRO, T-Mobile, KPN, the Municipality of Amsterdam, Mediq and various teaching hospitals.

In December 2021, the AMP Group made its first acquisition, Delta Logistics. Delta is the largest  independent logistics B2B solution provider specialized in actively refrigerated delivery of pharmaceutical and veterinary products throughout the Netherlands.

About Holland Capital
Over the past 40 years Holland Capital has reliably and successfully invested in more than 150 Dutch SMEs. With a clear investment strategy it is active in the attractive growth markets of Healthcare and Technology. The experienced and committed investment team knows what entrepreneurship is all about. It strives for an open, sustainable and professional relationship with management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs in Healthcare and Technology.

Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems

Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems

Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems

Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems

Amsterdam,  21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems. Holland Capital, together with BOM Capital, first joined CytoSMART in 2016 to help grow the company’s product portfolio and to stimulate commercial growth. In 2019, ECFG joined the investors in a Series B funding round, further accelerating commercial expansion and supporting continued product innovation. With the acquisition by Axion, CytoSMART can continue to roll out their R&D and commercial strategy at a global scale, helping advance live-cell imaging research even further.

Noninvasively studying the real-time biology of live cells allows scientists to obtain a more complete understanding of the complex processes underpinning health and disease. In their respective arenas, both Axion and CytoSMART have focused on the development of next-generation analysis tools for use in pharmaceutical, academic, and biotechnology research. Along with Axion’s recent acquisition of UK-based printed electronics manufacturer M-Solv Manufacturing Limited, this latest product portfolio expands the company’s offerings and opportunities in a rapidly growing life sciences tools market.

According to Joffry Maltha, CEO of CytoSMART, the mutually beneficial partnership is a natural fit. “Axion’s overall mission and corporate culture align with our efforts to provide scientists around the world with high-quality, easy-to-use products to advance their research goals. With Axion’s resources and experience, we look forward to accelerating our market growth and product innovation.”

 “In CytoSMART, we found a company with technology complementary to our own, as well as a partner with the same fundamental objective—to provide customers with high-quality instruments and powerful software that rapidly advance live-cell research and cell therapy development. We welcome the entire CytoSMART team, and we are excited to add their expertise to our own,” said Tom O’Brien, President & CEO of Axion BioSystems.

Jan Frens van Giessel, partner Holland Capital, said, “We’re very proud to see what major steps CytoSMART has realised within the life sciences industry and are excited to see that the partnership with Axion BioSystems allows the company to take the next step forward. We wish both companies continued success!”

About Axion BioSystems
Axion BioSystems is a leading life sciences tools company focused on innovative live-cell assays used to study the function of cells in vitro for drug discovery and disease modeling. The team at Axion BioSystems is dedicated to continuing the advancement of new technologies that accelerate research and further the understanding of biological complexity outside of the body. Axion BioSystems is headquartered in Atlanta, Georgia, USA, and has offices worldwide. Axion has more than 90 employees across its current locations. www.axionbiosystems.com

About CytoSMART
CytoSMART Technologies is a specialist in the development and manufacturing of live-cell imaging systems for life science laboratories. The company was founded in 2012 by a team of biologists and engineers who were convinced that a new generation of miniaturized microscopes, powered by artificial intelligence for image analysis, would allow biologists to make discoveries more efficiently and at scale. In 2018, CytoSMART was selected by Microsoft for its prestigious ScaleUp program. CytoSMART’s microscopy solutions are used in research laboratories worldwide. CytoSMART Technologies is headquartered in Eindhoven, the Netherlands, and has more than 50 employees.  www.cytosmart.com

About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.

YOEP Onderwijs & Zorg joins forces with Ad Astra

YOEP Onderwijs & Zorg joins forces with Ad Astra

YOEP Onderwijs & Zorg joins forces with Ad Astra

YOEP Onderwijs & Zorg joins forces with Ad Astra

Amsterdam, 14th of March 2022, Our portfolio company YOEP Onderwijs en Zorg is joining forces with Ad Astra Begeleiding & Behandeling, a youth care provider which focuses on the guidance and treatment of children and young adults. As a result of the merger, enabled by Holland Capital, an organisation arises with a broad offering in integrated youth care and mental health care (GGZ), which is of great added value for youth care.

Ad Astra offers guidance and treatment to children and young adults, aging from 6 to 23, who struggle due to development issues. Ad Astra focusses on specialized guidance, youth care and general primary health care (BGGZ).

Custom services through the use of innovative software        
Since both organizations operate in the intersection between education and healthcare, they complement each other seamlessly.  By working together with child, parents, school and others involved, YOEP and As Astra are able to offer custom services, leveraging their professional teams and innovative software, ”het Functioneringsprofiel”. This e-health app is used for screening, pre-diagnostic and monitoring to map the functioning of the child in a fast and comprehensive manner. By using het Functioneringsprofiel, custom services can be provided by YOEP and Ad Adstra, enabling the companies operate based on the “first time right” principle, hereby ensuring faster, much-needed care for the child or young adult. Furthermore, het Functioneringsprofiel provides support for efficient multi-disciplinary consultation as well as guidance during the health process, resulting in a reduction of healthcare costs.

Growth ambition YOEP

The merger between YOEP and Ad Astra is part of the envisioned growth ambitions of YOEP.

Simon van den Brekel, director YOEP, “with this acquisition we wish to ensure both continuity for our clients as well as for our employees. The merger of YOEP and Ad Astra will provide more integrated youth care, putting us a step closer to our ultimate goal: optimizing the care for our clients and providing care when needed in a result oriented manner.”

Marije Veen, director Ad Astra, “as as a result of this merger with YOEP, we are better equipped to provide effective and affordable youth care. Innovations and continuous improvement processes are the main drivers for our employees, as well as securing high customer satisfaction rates.” Marije Veen will join the board of YOEP Holding.

About Ad Astra        
Ad Astra was founded in 2008 and focusses, through 140 professionals, on specialized guidance, youth care and BGGZ in the regions Midden-Holland and Haaglanden.

About YOEP 
YOEP was founded by Michiel Noordzij (a child-and youth psychiatric) and Simon van den Brekel in 2015. The organization provides outpatient specialized healthcare (SGGZ) to children and young adults until the age of 23. YOEP employs more than 60 employees and is active in the regions Zuid-Holland, Midden-Holland, Haaglanden, Holland Rijnland, Amsterdam and Gooi en Vechtstreek.

About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.

Axual raises growth financing from investor Holland Capital

Axual raises growth financing from investor Holland Capital

Axual raises growth financing from investor Holland Capital

Axual raises growth financing from investor Holland Capital

Utrecht/Amsterdam, 10 March 2022 – Holland Capital is investing with a private co-investor in software company Axual, which provides customers with a platform that makes real-time data streaming easier and faster. With this funding, Axual aims to realize its growth ambitions.

Real-time data streaming
Axual’s software platform enables enterprises to utilize data streaming based on Apache Kafka technology. In this form of data streaming, events are displayed in a stream of real-time data, which can then trigger other processes within the organization, as well as enable real-time analysis. Axual provides tools and services to manage data streams and their associated applications in an enterprise-grade manner.

Big data
There is a growing demand for such real-time data streaming software. The large amount of data available today is interesting for many companies to use in, for example, improving customer experience or enhancing internal processes. Axual is a valued partner for medium to large sized companies in the financial and energy sectors, as well as in the retail and public sectors. Companies such as Rabobank, de Volksbank and Eneco use Axual to work fully data-driven. This includes use cases such as sending real-time notifications, fraud detection, real-time trading in energy and linking smart sensors to predict energy consumption.
Gartner also recognizes that using and sharing real-time data is a must-have for business. Recently, Axual was selected by Gartner as a “representative vendor” in their 2022 market report for event stream processing technologies.

Investment for growth
Through the partnership with Holland Capital, Axual will further invest in product development and (inter)national expansion of the platform.
Jeroen van Disseldorp, founder and CEO Axual, “Holland Capital’s investment makes it possible to finance our ambitious growth plans and expansion abroad.”
Hubert Verbeek, managing partner Holland Capital, “Axual has built a strong position in recent years and has positioned itself well in the market. We look forward to entering the next phase of growth together.”

About Axual
Axual was founded in 2015 by Jeroen van Disseldorp, the company is based in Utrecht and has 35 employees. Axual’s platform is complementary to Apache Kafka. Kafka’s leading technology is used by more than 80% of Fortune 100 companies. The Axual platform includes functionalities for data governance, audit trails, security and data synchronization, among others. Customers include Rabobank, Volksbank and Eneco.

About Holland Capital
Holland Capital has made responsible and successful investments in over 150 Dutch SME companies over the past 40 years. With a clear investment strategy it is active in the attractive growth markets of Healthcare and Technology. The experienced and committed investment team knows what entrepreneurship is. It strives for an open, sustainable and professional relationship with management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs in Healthcare and Technology. Axual is the first portfolio company of the recently launched Holland Capital Venture and Growth Fund IV. This fund was launched in November 2021 and we are currently working towards a second close for further interested parties.

Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions.

Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions.

Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions

Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions

3 February 2022, Holland Capital acquires Appronto, a low-code and integration solutions service provider. The company will closely collaborate with three companies of Holland Capital’s current portfolio: Magnus Digital, Dimensys, and cards PLM solutions. The acquisition yields a product and service offering that will fully serve clients with their challenges around Digital Transformation. The bundling of forces allows the four companies, that are centred around SAP, Siemens, Mendix, and Boomi technologies, to play an important role in the digitalization of the manufacturing industry also known as“Industry 4.0”.

The four companies will continue to operate under their own brand and, together with Holland Capital, aim to grow the service offering around Digital Transformation within the SAP, Siemens, Mendix, and Boomi technology space to become the leading partner in the Benelux and a top 5 player in Europe. The collaboration allows employees to foster, as they are able to develop themselves across the different business units of the joint companies, ultimately resulting in improved, end-to-end services for clients.

Altogether, the companies have a total of 320 employees and deliver a large contribution to organisations with a focus on Digital Transformation, especially around Industry 4.0.

Peter-Jan Simons, Managing Director Magnus and Dimensys: “The markets and services as a result of this new partnership are highly complementary, supported with plenty of overlap to understand each other’s language. The latter was directly noticeable during our Digital Transformation projects, where we bundled the sector expertise and services of the different companies.”

Erik Burghoorn, CEO cards PLM solutions: “Digital Transformation is a highly relevant topic that is becoming increasingly important for our clients. If anything, the COVID-19 pandemic has led to an even stronger surge in demand. The combination of knowledge and experience around SAP, Mendix, and Siemens makes us a very strong partner for both national and international clients.

Bas van der Horst, Managing Director Appronto: “The world is changing rapidly. New  business models and IT-architectures allow organisations to capture trends and stay ahead of the competition. The strong combination of knowledge and know-how in the field of ERP, low-code applications & integrations, and production solutions allows us to make our clients ‘winners’ in in the age of digitalisation.

Ewout Prins, Managing Director Holland Capital: “Digital Transformation in the manufacturing industry (Industry 4.0) is going through an enormous amount of growth. With the bundling of forces of these complementary technologies, we are perfectly positioned to satisfy the demand in the market. We are proud to facilitate this collaboration and to be of added value driving future growth.”

About Appronto Appronto was established in 2013 and focuses on the development of digital solutions for complex issues. Appronto specialises in the development of low-code solutions based on the Mendix-platform and the realisation of system integrations via Boomi’s cloud-based integration platform. Last year, Appronto not only became the first European Siemens Smart Expert Partner, but was also awarded the Boomi Partner Spotlight Award and Top Cloud Partner Siemens Benelux award.

About cards PLM solutions cards was established in 1999 and is based in Best (NL) and Genk (B). With a team of 56 employees, the organisation is specialised in the digitalisation of company processes and information streams within the manufacturing industry. Specifically, the company serves clients in the automotive, aerospace, high-tech, machine building, medical devices and consumer goods. Over the years, the company has transformed into a specialised Product Lifecycle Management (PLM) solutions provider. cards is a Siemens Platinum Smart Expert Partner for Siemens Digital Industries Software.

About Dimensys Dimensys was founded in 2000 and helps companies in achieving operational excellence in their specific company processes. Dimensys serves clients in, amongst others, the construction, infrastructure, and manufacturing industries. The company makes the lifecycle of assets and products transparent, predictable, and repeatable. Thus, its clients are better able to accurately and optimally make use of their products and assets. The company uses its long-standing experience in the knowledge domains Asset and Product Lifecycle Management, Project & Portfolio Management, and Supply Chain Management. Dimensys is a certified SAP Gold Partner, SAP Partner Center of Expertise and SAP Recognized Expert Partner.

About Magnus Digital Magnus, established in 1990, was the first SAP and one of the first Mendix partners in The Netherlands. Magnus Digital is an innovative partner for IT and organisational advice that works for leading clients: from advice to realisation. With around 100 consultants, the company delivers services in the areas of Digital Transformation, Data Analytics, ERP-implementations and the development of low-code solutions. Furthermore, the company unburdens clients by managing these services. Magnus Digital is active in, amongst others, retail, FMCG, wholesale, manufacturing, education, logistics, and construction sector.

About Holland Capital Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs in the relevant growth markets.